Clinical Trial: Peripheral Primitive Fibromatosis

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional

Official Title: Peripheral Primitive Fibromatosis. Study Evaluating a Simple Initial Monitoring With Search of Scalability Predictive Factors and Registration of Treatments in Case of Progression

Brief Summary: It's a monitoring study. The aim is to assess the progression free survival up to 3 years. Patients are not treated until progression. Search for scalability predictive factors and registration of treatments if progression.

Detailed Summary:
Sponsor: Gustave Roussy, Cancer Campus, Grand Paris

Current Primary Outcome: Progression Free Survival [ Time Frame: assessed up to 3 years ]

Original Primary Outcome: Same as current

Current Secondary Outcome: Functional result [ Time Frame: 1 year ]

Assessed with criteria for Adverse Effects-V4 scale once per year during the consultation


Original Secondary Outcome: Same as current

Information By: Gustave Roussy, Cancer Campus, Grand Paris

Dates:
Date Received: February 25, 2013
Date Started: May 2012
Date Completion: May 2018
Last Updated: June 8, 2016
Last Verified: June 2016